Evan A. Thackaberry
Corporate Officer/Principal presso VIGIL NEUROSCIENCE, INC.
Patrimonio netto: 3 870 $ in data 30/04/2024
Posizioni attive di Evan A. Thackaberry
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Corporate Officer/Principal | 01/09/2020 | - |
Storia della carriera di Evan A. Thackaberry
Precedenti posizioni note di Evan A. Thackaberry
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/10/2017 | 01/03/2020 |
Formazione di Evan A. Thackaberry
| University of Wisconsin | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
Posizioni
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Evan A. Thackaberry
- Esperienza
